AtriCure, Inc.
ATRC
$35.45
$0.361.01%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.37% | 10.13% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.37% | 10.13% | |||
| Cost of Revenue | -4.96% | 11.83% | |||
| Gross Profit | -0.15% | 9.56% | |||
| SG&A Expenses | -0.20% | 3.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.81% | 9.85% | |||
| Operating Income | 103.36% | -4.00% | |||
| Income Before Tax | 98.55% | 8.90% | |||
| Income Tax Expenses | -30.65% | 9.21% | |||
| Earnings from Continuing Operations | 95.69% | 8.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 95.69% | 8.26% | |||
| EBIT | 103.36% | -4.00% | |||
| EBITDA | 626.64% | -17.36% | |||
| EPS Basic | 95.68% | 8.92% | |||
| Normalized Basic EPS | 98.58% | 9.44% | |||
| EPS Diluted | 95.68% | 8.92% | |||
| Normalized Diluted EPS | 98.58% | 9.44% | |||
| Average Basic Shares Outstanding | 0.42% | 0.69% | |||
| Average Diluted Shares Outstanding | 0.42% | 0.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||